Literature DB >> 17484221

Prospective multinational study of pertussis infection in hospitalized infants and their household contacts.

Frank Kowalzik1, Arnaldo Prata Barbosa, Vera Regina Fernandes, Paulo Roberto Carvalho, Maria Luisa Avila-Aguero, Daniel Y T Goh, Anne Goh, Jesus Garcia de Miguel, Fernando Moraga, Joan Roca, Magda Campins, Ming Huang, Jorge Quian, Nicole Riley, Dominique Beck, Thomas Verstraeten.   

Abstract

BACKGROUND: Increased incidence of pertussis has been noted among infants too young to be immunized. We studied the disease burden of pertussis in pediatric intensive care units and the source of infection in several Asian, European and Latin American countries.
METHODS: The study was conducted in 7 countries from September 2001 to January 2004. Children <1 year of age were enrolled from pediatric intensive care units (PICU) and pediatric wards if they presented with respiratory failure, apnea, bradycardia, or cough accompanied by paroxysms, vomiting, whoop or cyanosis. Household members of pertussis-positive index cases were asked to answer a questionnaire and provide diagnostic specimens.
RESULTS: Pertussis was confirmed in 99 infants (12%) of 823 infants included in the analysis: 10 of 90 (11%) in Brazil, 9 of 88 (10%) in Costa Rica, 11 of 145 (8%) in Germany, 13 of 147 (9%) in Singapore, 29 of 67 (43%) in Spain, 2 of 86 (2%) in Taiwan and 25 of 200 (13%) in Uruguay. However, sensitivity analysis indicated that these figures were conservative. The mean (+/- SD) average age of infection was 2.6 +/- 2.2 months. Pertussis was found among 96 of 269 (36%) of household contacts investigated. At least one household contact was identified as the source of infection in 24 of 88 (27%) of the PICU cases and mothers were identified as being the most frequent source of infection.
CONCLUSION: Although regional differences exist, severe pertussis represents a considerable global disease burden. Since most infants are infected before vaccination and concomitant protection is completed, household contacts should be targeted for booster vaccination to reduce the pertussis reservoir.

Entities:  

Mesh:

Year:  2007        PMID: 17484221     DOI: 10.1097/01.inf.0000256750.07118.ee

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  25 in total

Review 1.  [Vaccination in adults].

Authors:  D M Kieninger-Baum; F Zepp
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

2.  Potential impact of parental Tdap immunization on infant pertussis hospitalizations.

Authors:  Timothy R Peters; Gretchen C Banks; Beverly M Snively; Katherine A Poehling
Journal:  Vaccine       Date:  2012-06-27       Impact factor: 3.641

3.  Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.

Authors:  Joanne Embree; Barbara Law; Tim Voloshen; Antigona Tomovici
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

4.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

Review 5.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Pertussis: not only a disease of childhood.

Authors:  Marion Riffelmann; Martina Littmann; Christel Hülße; Wiebke Hellenbrand; Carl Heinz Wirsing von König
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

7.  Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.

Authors:  S K Sharma; M E Pichichero
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

8.  Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.

Authors:  Robin de Vries; Mirjam Kretzschmar; Joop F P Schellekens; Florens G A Versteegh; Tjalke A Westra; John J Roord; Maarten J Postma
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

9.  Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.

Authors:  James D Cherry; Tina Tan; Carl-Heinz Wirsing von König; Kevin D Forsyth; Usa Thisyakorn; David Greenberg; David Johnson; Colin Marchant; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

10.  Clinical Characteristics of Hospitalized Infants With Laboratory-Confirmed Pertussis in Guatemala.

Authors:  Varun K Phadke; John P McCracken; Jennifer L Kriss; Maria R Lopez; Kim A Lindblade; Joe P Bryan; Miguel E Garcia; Carlos E Funes; Saad B Omer
Journal:  J Pediatric Infect Dis Soc       Date:  2018-12-03       Impact factor: 5.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.